陜西合成(cheng)(cheng)藥(yao)(yao)(yao)(yao)業(ye)(ye)股(gu)份有限(xian)公(gong)司(si)(si)(si)成(cheng)(cheng)立于(yu)(yu)2014年(nian),系(xi)由2009年(nian)4月成(cheng)(cheng)立的(de)(de)陜西合成(cheng)(cheng)藥(yao)(yao)(yao)(yao)業(ye)(ye)有限(xian)公(gong)司(si)(si)(si)整體改制變(bian)更成(cheng)(cheng)立,公(gong)司(si)(si)(si)于(yu)(yu)2015年(nian)3月在全國中(zhong)小企(qi)業(ye)(ye)股(gu)份轉讓系(xi)統(tong)成(cheng)(cheng)功掛牌(pai)(股(gu)票(piao)名稱:合成(cheng)(cheng)藥(yao)(yao)(yao)(yao)業(ye)(ye);股(gu)票(piao)代碼:832077),是(shi)專于(yu)(yu)藥(yao)(yao)(yao)(yao)品研究(jiu)開發、注冊申報(bao)(bao)的(de)(de)新藥(yao)(yao)(yao)(yao)技術企(qi)業(ye)(ye)。研發范圍涉及(ji)各(ge)類化學新藥(yao)(yao)(yao)(yao),并針(zhen)對目前(qian)上市的(de)(de)藥(yao)(yao)(yao)(yao)物缺陷進行結構修(xiu)飾,自主研發藥(yao)(yao)(yao)(yao)效更強、安全性更高的(de)(de)化學新藥(yao)(yao)(yao)(yao)。目前(qian)擁有合成(cheng)(cheng)藥(yao)(yao)(yao)(yao)業(ye)(ye)泰州(zhou)研發中(zhong)心和江蘇天地人和藥(yao)(yao)(yao)(yao)業(ye)(ye)有限(xian)公(gong)司(si)(si)(si)子公(gong)司(si)(si)(si)。公(gong)司(si)(si)(si)本著“嚴謹(jin)、務實、創新、進步”的(de)(de)理念,建立了新藥(yao)(yao)(yao)(yao)項目的(de)(de)情報(bao)(bao)搜集、立項、研發、申報(bao)(bao)的(de)(de)流程管(guan)理系(xi)統(tong)完整的(de)(de)新藥(yao)(yao)(yao)(yao)項目研發體系(xi)。
合成藥業是陜西省科(ke)技(ji)廳、財政廳、稅務(wu)局共(gong)同認定(ding)的(de)高新技(ji)術企業。
公(gong)(gong)司(si)(si)與揚子江藥(yao)業集團、哈爾(er)濱(bin)譽恒藥(yao)業股(gu)份有限(xian)(xian)公(gong)(gong)司(si)(si)、武漢福星(xing)生物藥(yao)業有限(xian)(xian)公(gong)(gong)司(si)(si)、北(bei)京凱(kai)因藥(yao)業股(gu)份有限(xian)(xian)公(gong)(gong)司(si)(si)、西安天一秦昆(kun)制(zhi)藥(yao)有限(xian)(xian)責任公(gong)(gong)司(si)(si)、北(bei)京美迪康信醫(yi)藥(yao)科技有限(xian)(xian)公(gong)(gong)司(si)(si)等十幾家國(guo)內藥(yao)企建立(li)了(le)良好的(de)合(he)作關(guan)系。
合(he)成藥業(ye)將(jiang)以科技創新的核心動(dong)力(li),不斷強化核心技術水(shui)平、規范經(jing)營(ying)管理體系,為全人類(lei)的健康事業(ye)奮進!